127 related articles for article (PubMed ID: 20190878)
1. In-vitro Release of Rapamycin from a Thermosensitive Polymer for the Inhibition of Vascular Smooth Muscle Cell Proliferation.
Zhu W; Masaki T; Cheung AK; Kern SE
J Bioequivalence Bioavailab; 2009 May; 1():3-12. PubMed ID: 20190878
[TBL] [Abstract][Full Text] [Related]
2. Cellular pharmacokinetics and pharmacodynamics of dipyridamole in vascular smooth muscle cells.
Zhu W; Masaki T; Cheung AK; Kern SE
Biochem Pharmacol; 2006 Oct; 72(8):956-64. PubMed ID: 16939681
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of neointimal hyperplasia in vascular grafts by sustained perivascular delivery of paclitaxel.
Masaki T; Rathi R; Zentner G; Leypoldt JK; Mohammad SF; Burns GL; Li L; Zhuplatov S; Chirananthavat T; Kim SJ; Kern S; Holman J; Kim SW; Cheung AK
Kidney Int; 2004 Nov; 66(5):2061-9. PubMed ID: 15496180
[TBL] [Abstract][Full Text] [Related]
4. Development of a sustained-release system for perivascular delivery of dipyridamole.
Zhu W; Masaki T; Bae YH; Rathi R; Cheung AK; Kern SE
J Biomed Mater Res B Appl Biomater; 2006 Apr; 77(1):135-43. PubMed ID: 16206204
[TBL] [Abstract][Full Text] [Related]
5. Correlation of tissue drug concentrations with in vivo magnetic resonance images of polymer drug depot around arteriovenous graft.
Owen SC; Li H; Sanders WG; Cheung AK; Terry CM
J Control Release; 2010 Aug; 146(1):23-30. PubMed ID: 20457189
[TBL] [Abstract][Full Text] [Related]
6. Arterial and venous smooth-muscle cells differ in their responses to antiproliferative drugs.
Kim SJ; Masaki T; Leypoldt JK; Kamerath CD; Mohammad SF; Cheung AK
J Lab Clin Med; 2004 Sep; 144(3):156-62. PubMed ID: 15454885
[TBL] [Abstract][Full Text] [Related]
7. Rapamycin-loaded nanoparticles for inhibition of neointimal hyperplasia in experimental vein grafts.
Zou J; Zhang X; Yang H; Zhu Y; Ma H; Wang S
Ann Vasc Surg; 2011 May; 25(4):538-46. PubMed ID: 21549923
[TBL] [Abstract][Full Text] [Related]
8. ReGel polymer-based delivery of interleukin-2 as a cancer treatment.
Samlowski WE; McGregor JR; Jurek M; Baudys M; Zentner GM; Fowers KD
J Immunother; 2006; 29(5):524-35. PubMed ID: 16971808
[TBL] [Abstract][Full Text] [Related]
9. Rapamycin reduces neointima formation during vascular injury.
Hilker M; Buerke M; Guckenbiehl M; Schwertz H; Bühler J; Moersig W; Hake U; Oelert H
Vasa; 2003 Feb; 32(1):10-3. PubMed ID: 12677758
[TBL] [Abstract][Full Text] [Related]
10. Sustained release of heparin from polymeric particles for inhibition of human vascular smooth muscle cell proliferation.
Yang Z; Birkenhauer P; Julmy F; Chickering D; Ranieri JP; Merkle HP; Lüscher TF; Gander B
J Control Release; 1999 Aug; 60(2-3):269-77. PubMed ID: 10425332
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of local dipyridamole therapy in a porcine model of arteriovenous graft stenosis.
Kuji T; Masaki T; Goteti K; Li L; Zhuplatov S; Terry CM; Zhu W; Leypoldt JK; Rathi R; Blumenthal DK; Kern SE; Cheung AK
Kidney Int; 2006 Jun; 69(12):2179-85. PubMed ID: 16672912
[TBL] [Abstract][Full Text] [Related]
12. Role of Girdin in intimal hyperplasia in vein grafts and efficacy of atelocollagen-mediated application of small interfering RNA for vein graft failure.
Miyachi H; Mii S; Enomoto A; Murakumo Y; Kato T; Asai N; Komori K; Takahashi M
J Vasc Surg; 2014 Aug; 60(2):479-489.e5. PubMed ID: 23948670
[TBL] [Abstract][Full Text] [Related]
13. T-cadherin promotes vascular smooth muscle cell dedifferentiation via a GSK3β-inactivation dependent mechanism.
Frismantiene A; Dasen B; Pfaff D; Erne P; Resink TJ; Philippova M
Cell Signal; 2016 May; 28(5):516-530. PubMed ID: 26907733
[TBL] [Abstract][Full Text] [Related]
14. Drug packaging and delivery using perfluorocarbon nanoparticles for targeted inhibition of vascular smooth muscle cells.
Zhou ZX; Zhang BG; Zhang H; Huang XZ; Hu YL; Sun L; Wang XM; Zhang JW
Acta Pharmacol Sin; 2009 Nov; 30(11):1577-84. PubMed ID: 19890365
[TBL] [Abstract][Full Text] [Related]
15. Development of a local perivascular paclitaxel delivery system for hemodialysis vascular access dysfunction: polymer preparation and in vitro activity.
Melhem M; Kelly B; Zhang J; Kasting G; Li J; Davis H; Heffelfinger S; Desai P; Roy-Chaudhury P
Blood Purif; 2006; 24(3):289-98. PubMed ID: 16465049
[TBL] [Abstract][Full Text] [Related]
16. Different responses by cultured aortic and venous smooth muscle cells to gamma radiation.
Kim SJ; Masaki T; Rowley R; Leypoldt JK; Mohammad SF; Cheung AK
Kidney Int; 2005 Jul; 68(1):371-7. PubMed ID: 15954929
[TBL] [Abstract][Full Text] [Related]
17. Smooth muscle cells orchestrate the endothelial cell response to flow and injury.
Balcells M; Martorell J; Olivé C; Santacana M; Chitalia V; Cardoso AA; Edelman ER
Circulation; 2010 May; 121(20):2192-9. PubMed ID: 20458015
[TBL] [Abstract][Full Text] [Related]
18. Fucans, sulfated polysaccharides extracted from brown seaweeds, inhibit vascular smooth muscle cell proliferation. I. Comparison with heparin for antiproliferative activity, binding and internalization.
Logeart D; Prigent-Richard S; Jozefonvicz J; Letourneur D
Eur J Cell Biol; 1997 Dec; 74(4):376-84. PubMed ID: 9438134
[TBL] [Abstract][Full Text] [Related]
19. Modulation of vascular cell growth kinetics by local cytokine delivery from fibrin glue suspensions.
Shireman PK; Hampton B; Burgess WH; Greisler HP
J Vasc Surg; 1999 May; 29(5):852-61; discussion 862. PubMed ID: 10231637
[TBL] [Abstract][Full Text] [Related]
20. Role for p27(Kip1) in Vascular Smooth Muscle Cell Migration.
Sun J; Marx SO; Chen HJ; Poon M; Marks AR; Rabbani LE
Circulation; 2001 Jun; 103(24):2967-72. PubMed ID: 11413088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
